Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1327 clinical trials
The Effect of The Personalized Patient Engagement Plan on Diabetes Management

This study evaluates the effect of Personalized Patient Engagement Plan on diabetes management in patients with at least six months of Type-2 Diabetes. The research is planned to be carried out as an experimental study with pretest-posttest control groups. Half of the participants will receive the Personalized Patient Engagement Plan; …

antidiabetic agent
antidiabetic agents
  • 0 views
  • 19 Feb, 2024
  • 2 locations
An N-of-1 Trial of an Internet-delivered CBT Program Based on the Psychological Flexibility Model of Chronic Pain for Cancer-related Difficulties

</p><p>The investigators will pilot test the modified treatment program in N-of-1 Trials that permit to estimate both between and within subject treatment effects, as well as processes that explain treatment outcome at the individual level, with a high degree of confidence.</p>

  • 0 views
  • 15 Jan, 2025
  • 1 location
Effect of Nutritional Supplementation and Pulmonary Rehabilitation on the Clinical Status of HF and COPD

Therefore, it is vitally essential to contemplate the supplementation with amino acids that prevent and delay the loss of protein reserves, as well as the delay in clinical status. The -hydroxy--methyl butyrate (HMB) is a metabolite of leucine, with an anticatabolic and anabolic effect.

lung disorder
pulmonary rehabilitation
pulmonary disease
spirometry
post bronchodilator spirometry
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

This is an open-label, dose escalation study to evaluate the safety, toxicity, and pharmacokinetics (PK) as well as preliminary efficacy of BTX-A51 capsules in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS).

myelodysplastic syndrome
leukemia
acute myeloid leukemia
exhausted
refractory aml
  • 0 views
  • 19 Feb, 2024
  • 1 location
Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX)

Nivolumab (anti-PD1) has been approved for patients progressing on or after platinum-based therapy, as it clearly impacts on overall survival. This randomized phase II study will evaluate the efficacy of nivolumab plus paclitaxel for first-line treatment of recurrent or metastatic HNSCC in the platinum ineligible and platinum refractory settings.

ct scan
metastatic head and neck squamous cell cancer
major surgery
paclitaxel
neck cancer
  • 0 views
  • 19 Feb, 2024
  • 20 locations
Multi-CAR-T Cells Targeting B Cell Lymphomas

This study aims to evaluate safety and efficacy of a combination of 4th generation chimeric antigen receptor gene-modified T cells targeting B cell surface molecules including CD19 and alternative CARTs as booster and consolidation treatment for patients with highly resistant B cell lymphomas, including primary mediastinal B cell lymphoma (PMBCL) …

  • 0 views
  • 19 Feb, 2024
  • 3 locations
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow …

vasectomy
brigatinib
measurable disease
intrauterine device (iud)
karnofsky performance status
  • 0 views
  • 19 Feb, 2024
  • 2 locations
Enzalutamide Treatment in COVID-19

Enzalutamide is an antiandrogen inhibiting the expression of androgen regulated proteins, such as TMPRSS2. The aim of this trial is to evaluate a possible beneficial effect of short-term enzalutamide treatment of COVID-19 patients.

enzalutamide
covid-19
oral contraceptives
  • 0 views
  • 19 Feb, 2024
  • 2 locations
AcceleRET Lung Study of Pralsetinib for 1L RET Fusion-positive Metastatic NSCLC

This is an international, randomized, open-label, Phase 3 study designed to evaluate whether the potent and selective RET inhibitor, pralsetinib, improves outcome when compared to a platinum chemotherapy-based regimen chosen by the Investigator from a list of standard of care treatments, as measured primarily by progression free survival (PFS), for …

non-small cell lung cancer
adenocarcinoma
platinum-based chemotherapy
head and neck neoplasms
cancer
  • 0 views
  • 19 Feb, 2024
  • 1 location
The Alberta NutrIMM Study - Nutrition and Immunity

Results of the study will be compared to results of the control group (which will go through the same activities as the experimental groups).

heart disease
type 2 diabetes mellitus
lipoprotein cholesterol
hemoglobin a1c
hdl cholesterol
  • 0 views
  • 19 Feb, 2024
  • 1 location